Davasaicin

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDavasaicin
Drug Alias NameCapsavanil达伐塞辛davasaicinadavasaicinumKR-25018
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVanilloid receptor agonists
TargetsTransient receptor potential cation channel subfamily V member 1
Therapy Area/IndicationsNeuralgia, Postherpetic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKorea Research Institute Of Chemical Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKorea Research Institute Of Chemical TechnologyStiefel Laboratories IncDong-A Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsNeuralgia, Postherpetic

Other Information

ATC CodeN/A
Related LinksN/A